Disclosures - Todd SCHLESINGER

> Did you receive any funding to support your research for this TOPIC?
No

> Were you provided with any honoraria, payment, or other compensation for your work on this study?
No

> Do you have any financial relationship with any entity which may closely compete with the medications, materials, or instruments covered by your study?
Yes
Please specify entities (individual, company, society): Consulting honoraria from Abbvie, Allergan, Almirall, Arcutis, Biofrontera, BMS, Castle Bioscience, CMS Aesthetics DCME, EPI Health, Foundation for Research and Education in Dermatology, Galderma, Genentech, Kintor, Lilly, Merz, Nextphase, Novartis, Ortho Dermatologics, Pharmatecture, Pierre Fabre, Plasmed, Prolacta Bioscience, Pulse Biosciences, Regeneron, Skinceuticals/L’Oreal, RBC Consultants, Sun Pharma, UCB, and Verrica. Grant/Research funding from Abbvie, Aclaris, Allergan, Amgen, Anterios, AO Biome, Arcutis Premier Research, ASLAN, Astellas Pharma US, Athenex, Biofrontera, Biorasi, Boehringer Ingelheim, Brickell Biotech, BMS, Cara Therapeutics, Castle Bioscience, Celgene, Chemocentryx, Coherus Bioscience, Concert Pharmaceutical (Now SUN Pharmaceuticals), Corrona, Cutanea Life Sciences, Dermavant, Dermira, DT Pharmacy & DT Collagen, EPI Health, Galderma, Janssen, Kiniksa, Leo, Lilly, Merz, Nestle, Nimbus, Novartis, Pfizer, Processa, Pulse Biosciences, Regeneron, Sanofi Genzyme, Sisaf, Trevi, and Verrica. Speakers’ Bureau/Advisory Board honoraria from Abbvie, Almirall, Amgen, Arcutis, Bioderma, BMS Biofrontera, Galderma, Sun Pharma, Leo, Lilly, Sanofi and Regeneron. Owns stock from Amgen, BMS, Lilly, and Remedly. Salary from Avant Health.

> Do you own or have you applied for any patents in conjunction with the instruments, medications, or materials discussed in your study?
No

This work was not supported by any direct or indirect funding. It is under the author's own responsibility